Goldenwell Biotech annual total assets
2019
2020
2021
2022
2023
2024
2025
Goldenwell Biotech Total Assets Growth & History (GWLL)
Goldenwell Biotech's total assets was $36,120 for fiscal 2025.
View full Goldenwell Biotech company overviewGoldenwell Biotech annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $36,120 | −$188,072 | −83.89% |
| 2024 | 2024-12-31 | $224,192 | −$3,902 | −1.71% |
| 2023 | 2023-12-31 | $228,094 | −$20,306 | −8.17% |
| 2022 | 2022-12-31 | $248,400 | −$212,579 | −46.11% |
| 2021 | 2021-12-31 | $460,979 | $212,410 | +85.45% |
| 2020 | 2020-12-31 | $248,569 | $1,976 | +0.80% |
| 2019 | 2019-12-31 | $246,593 | — | — |
Goldenwell Biotech quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $28,978 | −$238,337 | −89.16% |
| Q1 2026 | 2026-03-31 | $18,754 | −$173,161 | −90.23% |
| Q4 2025 | 2025-12-31 | $36,120 | −$188,072 | −83.89% |
| Q3 2025 | 2025-09-30 | $233,760 | $54,328 | +30.28% |
| Q2 2025 | 2025-06-30 | $267,315 | $66,917 | +33.39% |
| Q1 2025 | 2025-03-31 | $191,915 | −$7,053 | −3.54% |
| Q4 2024 | 2024-12-31 | $224,192 | −$3,902 | −1.71% |
| Q3 2024 | 2024-09-30 | $179,432 | −$7,501 | −4.01% |
| Q2 2024 | 2024-06-30 | $200,398 | $8,059 | +4.19% |
| Q1 2024 | 2024-03-31 | $198,968 | −$20,454 | −9.32% |
| Q4 2023 | 2023-12-31 | $228,094 | −$20,306 | −8.17% |
| Q3 2023 | 2023-09-30 | $186,933 | −$79,144 | −29.74% |
| Q2 2023 | 2023-06-30 | $192,339 | −$82,061 | −29.91% |
| Q1 2023 | 2023-03-31 | $219,422 | −$89,264 | −28.92% |
| Q4 2022 | 2022-12-31 | $248,400 | −$212,579 | −46.11% |
| Q3 2022 | 2022-09-30 | $266,077 | −$219,770 | −45.23% |
| Q2 2022 | 2022-06-30 | $274,400 | −$234,776 | −46.11% |
| Q1 2022 | 2022-03-31 | $308,686 | −$126,493 | −29.07% |
| Q4 2021 | 2021-12-31 | $460,979 | $212,410 | +85.45% |
| Q3 2021 | 2021-09-30 | $485,847 | $235,303 | +93.92% |
| Q2 2021 | 2021-06-30 | $509,176 | — | — |
| Q1 2021 | 2021-03-31 | $435,179 | — | — |
| Q4 2020 | 2020-12-31 | $248,569 | $1,976 | +0.80% |
| Q3 2020 | 2020-09-30 | $250,544 | — | — |
| Q4 2019 | 2019-12-31 | $246,593 | — | — |
Goldenwell Biotech total assets trends
Over the last five fiscal years, Goldenwell Biotech's total assets decreased from $248,569 to $36,120, a change of −$212,449. The latest reported quarter, Q2 2026, shows $28,978.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Goldenwell Biotech source filings ↗